about
Polymorphisms of NRF2 and NRF2 target genes in urinary bladder cancer patients.Matrix metalloproteinases and genetic mouse models in cancer research: a mini-review.Lipid peroxidation and glutathione peroxidase activity relationship in breast cancer depends on functional polymorphism of GPX1.Biological monitoring and the influence of genetic polymorphism of As3MT and GSTs on distribution of urinary arsenic species in occupational exposure workers.MMP7 and MMP8 genetic polymorphisms in bladder cancer patients.Functional polymorphisms in the matrix metalloproteinase genes and their association with bladder cancer risk and recurrence: a mini-review.Rotating night shift work and polymorphism of genes important for the regulation of circadian rhythm.Circadian gene methylation in rotating-shift nurses: a cross-sectional study.mRNA, microRNA and lncRNA as novel bladder tumor markers.MMP, VEGF and TIMP as prognostic factors in recurring bladder cancer.Genetic polymorphisms in matrix metalloproteinases (MMPs) and tissue inhibitors of MPs (TIMPs), and bladder cancer susceptibility.Association between plasma selenium level and NRF2 target genes expression in humans.GSTP1 mRNA expression in human circulating blood leukocytes is associated with GSTP1 genetic polymorphismA different methylation profile of circadian genes promoter in breast cancer patients according to clinicopathological features
P50
Q34161803-DAB3C32E-9646-4D33-8E63-9011F7E1FBACQ35043525-AE5EC3F9-8563-495F-99DD-EF3B9D310467Q35800890-EF2A6E5E-F9CD-4F89-8354-93DABB11B767Q35868551-0A7CFB3F-B30D-47D9-9D1F-FF4D209861A9Q37711553-8277F408-E984-438A-85D2-FA813A280847Q38196442-4243A4C6-E8AC-4DC6-B323-56DBF271839CQ45152161-F0F37179-A709-40D5-BBEF-0BBEB7502AC2Q48291945-A54D9923-009C-45F1-98FF-8C6E66C4F361Q49965050-3FB9B77B-8A7B-4413-8BF8-0EECCAF0B420Q50254273-5E3E09A1-49B1-463C-8434-EDE3342FAFD0Q50863404-EE520B45-6E12-4486-A0DF-451C2EB44EE2Q53226218-91310DD7-1DD8-48C1-BE4C-C65EB85DA41DQ84350377-B07E3127-92F8-4EE1-B463-E0EA09EA406EQ92623738-A4B4229E-EC9F-4509-92A1-B6F11009A875
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Edyta Wieczorek
@ast
Edyta Wieczorek
@en
Edyta Wieczorek
@es
Edyta Wieczorek
@nl
type
label
Edyta Wieczorek
@ast
Edyta Wieczorek
@en
Edyta Wieczorek
@es
Edyta Wieczorek
@nl
prefLabel
Edyta Wieczorek
@ast
Edyta Wieczorek
@en
Edyta Wieczorek
@es
Edyta Wieczorek
@nl
P106
P31
P496
0000-0002-4390-2042